Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Treatment of γ-Hydroxybutyric Acid and γ-Butyrolactone Overdose with Two Potent Monocarboxylate Transporter 1 Inhibitors, AZD3965 and AR-C155858.

Follman KE, Morris ME.

J Pharmacol Exp Ther. 2019 Jul;370(1):84-91. doi: 10.1124/jpet.119.256503. Epub 2019 Apr 22.

PMID:
31010842
2.

Simulation-Based Analysis of the Impact of Renal Impairment on the Pharmacokinetics of Highly Metabolized Compounds.

Follman KE, Morris ME.

Pharmaceutics. 2019 Mar 2;11(3). pii: E105. doi: 10.3390/pharmaceutics11030105.

3.

Effects of renal impairment on transporter-mediated renal reabsorption of drugs and renal drug-drug interactions: A simulation-based study.

Follman KE, Dave RA, Morris ME.

Biopharm Drug Dispos. 2018 Apr;39(4):218-231. doi: 10.1002/bdd.2128.

4.

Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study.

Follman KE, Morris ME.

Drug Metab Dispos. 2018 May;46(5):758-769. doi: 10.1124/dmd.117.079558. Epub 2018 Feb 28.

5.

The Drug of Abuse Gamma-Hydroxybutyric Acid Exhibits Tissue-Specific Nonlinear Distribution.

Felmlee MA, Morse BL, Follman KE, Morris ME.

AAPS J. 2017 Dec 26;20(1):21. doi: 10.1208/s12248-017-0180-7.

6.

Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.

Morse BL, Chadha GS, Felmlee MA, Follman KE, Morris ME.

Am J Drug Alcohol Abuse. 2017 Nov;43(6):686-693. doi: 10.1080/00952990.2017.1339055. Epub 2017 Jun 29.

7.

γ-Hydroxybutyric Acid (GHB) Pharmacokinetics and Pharmacodynamics: Semi-Mechanistic and Physiologically Relevant PK/PD Model.

Dave RA, Follman KE, Morris ME.

AAPS J. 2017 Sep;19(5):1449-1460. doi: 10.1208/s12248-017-0111-7. Epub 2017 Jun 26.

Supplemental Content

Loading ...
Support Center